This local biotech says it has found a way to trick cancer cells into destroying themselves with its molecular glue. Now it's ...

Experts debate MMR/p53 testing, liquid biopsy, and immunotherapy sequencing in endometrial cancer, refining prognosis and relapse treatment.

In 2025, Pfizer PFE upped its efforts to rebuild its pipeline through acquisitions. Pfizer invested around $9 billion in M&A ...

Astellas surpassed market expectations in its third-quarter fiscal year 2025 results, as first-in-class cancer drug Vyloy defied a trial setback to deliver quadrupled sales. | Astellas surpassed ...

Dr Robert Amesiya, Acting Greater Accra Regional Director Ghana Health Service, has encouraged women to regularly screen for breast ...

Nurse practitioner Nikki Shaffer, a senior director of Global Colleague Wellness at Pfizer, joins "CBS Mornings" to mark ...

Working With Cancer was launched by Sadoun and Publicis Groupe three years ago in Davos at the World Economic Forum. The tool is available to all companies signed up to the pledge, which currently ...

Collaborators at WashU Medicine developed a tool to detect infections early among patients who have had breast reconstruction after cancer, potentially allowing for preemptive treatment that preserves ...

Sadoun speaks to Campaign about survivors’ loss of confidence after a diagnosis and Publicis Groupe's 'most important' work.

According to the American Cancer Society, over two million Americans will be diagnosed with cancer in 2026. Dr. Jen Caudle, a ...

Amgen is refusing U.S. regulators’ request to withdraw an inflammatory disease drug. Elsewhere, Pfizer battled skepticism on ...